OCGN · CIK 0001372299 · FY2025 live · 2025-12-31
Ocugen, Inc.
View as
Model
Classic Z
FY2025
−17.89
Zone
Distress
Prior
—
Market DD
—
1y PD
—
−17.89
Z″ −40.32
Score −17.89 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.031.2 × = 0.04X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−9.381.4 × = −13.13X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−1.453.3 × = −4.77X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
−0.220.6 × = −0.13X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.101 × = 0.10
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings.
Meridian Rank
4.82
0–100 · Classic Z family
Book standing
4
Year change
—
Market PD
—
O-score
7
Events on this name
Same published rows as Today.
No published events on this print.
Overview
rule-v1
Ocugen, Inc. is on classic Z at −17.89 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers. Buybacks can send retained earnings negative at otherwise healthy issuers. X4 is book equity.
Book screen Distress; market PD —. Market PD has not been priced on this name.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 7th percentile in Healthcare.
- ABUSDistressArbutus Biopharma Corp−17.93
- PASGDistressPassage BIO, Inc.−17.72
- CLGNDistressCollPlant Biotechnologies Ltd−18.27
- SNOADistressSonoma Pharmaceuticals, Inc.−18.54
- INKTDistressMiNK Therapeutics, Inc.−18.57
- LFWDDistressLifeward Ltd.−18.73
- FTHDistressFaeth Therapeutics, Inc.−17.03
- PPCBDistressPropanc Biopharma, Inc.−16.96
Filing line items
Current assets
$24M
Total assets
$44M
Current liabilities
$23M
Total liabilities
$56M
Working capital
$1M
Retained earnings
−$408M
EBIT
−$63M
Total sales
$4M
Book equity
−$12M
Accession 0001628280-26-014435. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as is a display overlay. X4 is book equity. Pulled 13 Sept 2026.